Accessibility
As part of our vision of a healthier world we want to make evidence-based resources available to as many people as possible. Each year we support more than 50 million users from over 150 countries to access our websites and products.
A key part of achieving our vision is to ensure our content is accessible to everyone, both through innovative technical solutions and through jargon-free, practical and customisable evidence-based content.
Our accessibility standard
BMJ Group’s websites and mobile applications adhere to the Web Content Accessibility Guidelines version 2.1 level A, wherever viable. Our objective is accessibility by design to ensure we achieve the guidelines and standards outlined by the World Wide Web Consortium (W3C) in their Web Content Accessibility Guidelines. Our in-house User Experience (UX), Developers and Multimedia teams all undergo accessibility training and we strive to work with suppliers and partners with the same standards.
We know some of our websites and mobile applications are not currently fully accessible, so we are currently reviewing existing standards across all of our websites and mobile applications and aim to publish details of the areas where we think there is scope for improvement in the future.
How we test our platforms
We are always looking to improve the accessibility of our websites and mobile applications. New products will be tested to ensure they meet our accessibility standards prior to release. We test all of our existing websites and mobile platforms periodically every three years.
Support
We welcome your feedback. If you find any problems accessing our content or think there’s more we could be doing to make the accessibility of our websites and mobile applications better please contact:
- email support@bmj.com
- call +44 (020) 7387 4410; or
- write to BMJ Publishing Group Limited, BMA House, Tavistock Square, London, WC1H 9JP.
This statement was last updated on 16 September 2020.
